Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-272-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The skin irritation potential of Copper
glucoheptonate (CAS 1821694 -24 -9) was tested in vivo in rabbits. It
was applied undiluted, semiocclusive
for 4 h. It was reported to be not irritating (Patel, 2016A, acc. OECD
404).
The eye irritation potential of Copper glucoheptonate (CAS 1821694 -24 -9) was tested in vivo in rabbits. It was applied as 1 % dilution in distilled water. It was reported to be not irritating (Patel, 2016B, acc. OECD 405).
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 15, 2016 - March 10, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: well documented GLP Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
- Deviations:
- yes
- Remarks:
- Exception to guideline 404, for not testing weight of evidence analysis by the test facility.
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Sainath Agencies, Hyderabad, India
- Age at study initiation: 4 to 5 months
- Weight at study initiation: Minimum: 2.406, Maximum: 2.560
- Housing: individually in stainless steel wire meshed cages were used.
- Diet (e.g. ad libitum): Teklad certified Global High Fiber Rabbit pellet Feed manufactured by Harlan, USA ad libitum
- Water (e.g. ad libitum): UV sterilised drinking water filtered through Kent Reverse Osmosis water filtration system ad libitum
- Acclimation period: 6 to 8 days
Animal Identification
Each rabbit was uniquely numbered on the ear using a tattoo machine. Appropriate labels were attached to the cages indicating the study number, test item code, sex, dose, type of study, cage number and animal number.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 22 °C
- Humidity (%): 63 to 65%
- Air changes (per hr): minimum 15 air changes/hour
- Photoperiod (hrs dark / hrs light): 12 h artificial light and 12 h darkness, light hours being 06:00 - 18:00 h - Type of coverage:
- semiocclusive
- Preparation of test site:
- clipped
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 500 mg
- Concentration (if solution): 1 % - Duration of treatment / exposure:
- 4 hours
- Observation period:
- The skin reactions of each rabbit were observed at 1, 24, 48 and 72 h post patch removal.
- Number of animals:
- 3
- Details on study design:
- TEST SITE
- Area of exposure: 6 cm²
- Type of wrap if used: gauze patch that was secured at the margins by non-irritating tape for a period of 4 h
REMOVAL OF TEST SUBSTANCE
- Washing (if done): At the end of the 4 h exposure period, the residual test item was removed with cotton soaked in distilled water.
- Time after start of exposure: 4 hours
SCORING SYSTEM:
Irritation was scored according to OECD 404. - Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- other: 24
- Score:
- 0
- Reversibility:
- other: not applicable
- Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- other: 48
- Score:
- 0
- Reversibility:
- other: not applicable
- Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- other: 72
- Score:
- 0
- Reversibility:
- other: not applicable
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- other: 24
- Score:
- 0
- Reversibility:
- other: not applicable
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- other: 48
- Score:
- 0
- Reversibility:
- other: not applicable
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- other: 72
- Score:
- 0
- Reversibility:
- other: not applicable
- Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- other: 24, 48 and 72 h
- Score:
- 0
- Irritant / corrosive response data:
- There were no signs of systemic adverse effect in any treated rabbits.
Erythema was evident at 1 h in all rabbits which resolved by 24 h post patch removal in all rabbits. The mean dermal irritation scores at 24, 48 and 72 h post-patch removal for individual animals were 0.00, 0.00, 0.00 for erythema and 0.00, 0.00, 0.00 for oedema, respectively. - Interpretation of results:
- not irritating
- Conclusions:
- Based on the results of this study, and the Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2015), DABQUEL COMPLEX CuP is not classified as a skin irritant
- Executive summary:
In an acute dermal irritation study, three adult male New Zealand White rabbits were dermally exposed to 500 mg DABQUEL COMPLEX CuP (pulverised and moistened with 0.5 mL distilled water), for 4 h (day 0), applied to approximately 6 cm² area of skin. Initially one rabbit was tested with a single patch applied evenly to the intact skin for a period of 4 h. Based on the observations at 24 h post patch removal, two additional rabbits were tested simultaneously to confirm the irritation response. The control skin site of each rabbit was untreated. The treated and the control sites were covered with a gauze patch that was secured at the margins by non-irritating tape for a period of 4 h. At the end of the 4 h exposure period, the residual test item was removed with cotton soaked in distilled water. The skin reactions of each rabbit were observed at 1, 24, 48 and 72 h post patch removal. Irritation was scored according to OECD 404.
There were no signs of systemic adverse effect in any treated rabbits.
Erythema was evident at 1 h in all rabbits which resolved by 24 h post patch removal in all rabbits. The mean dermal irritation scores at 24, 48 and 72 h post-patch removal for individual animals were 0.00, 0.00, 0.00 for erythema and 0.00, 0.00, 0.00 for oedema, respectively.
Based on the results of this study, an indication of the classification for DABQUEL COMPLEX CuP is as follows:
Globally Harmonized System of Classification and Labeling of Chemicals (GHS 2015): Not classified as a skin irritant
Reference
Mean Dermal Irritation Score
The mean dermal irritation scores at 24, 48 and 72 h post-patch removal for animal Nº 1, 2 and 3 were 0.00, 0.00, 0.00 for erythema and 0.00, 0.00, 0.00 for oedema, respectively (TABLE 2).
Narrative Description of Skin Reactions
Following the 4 h exposure period (day 0), the skin of each rabbit was observed at 1, 24, 48 and 72 h post patch removal.
At 1 h post patch removal, the treated skin site revealed very slight erythema (barely perceptible) in all three rabbits (TABLE 1).
At 24 h post patch TIA, the treated skin site recovered completely and appeared normal in all three rabbits throughout the experimental period (TABLE 1).
The control skin sites of all three rabbits were normal with no erythema and no oedema observed throughout the experimental period (TABLE 1).
Clinical Observations other than Dermal Irritation
No clinical signs were observed in any rabbit throughout the experimental period (TABLE 2).
Interpretation of Results
The mean scores of erythema (0.00) and oedema (0.00) observed at the 24, 48 and 72 h post patch removal observation time-points indicated that the DABQUEL COMPLEX CuP is a non-irritant under the described experimental conditions.
Acute Dermal Irritation Study of DABQUEL COMPLEX CuP in Rabbits
TABLE1: Dermal Irritation Scores
Control Site: Untreated Sex: Male
Rabbit N° |
Site of Application |
Observations after Patch Removal |
|||||||
Erythema |
Oedema |
||||||||
Hour |
Hour |
||||||||
1 |
24 |
48 |
72 |
1 |
24 |
48 |
72 |
||
1 |
Right |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Right |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
Left |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Treated Site: 500 mg DABQUEL COMPLEX CuP (pulverised and moistened with 0.5 mL distilled water)
Rabbit N° |
Site of Application |
Observations after Patch Removal |
|||||||
Erythema |
Oedema |
||||||||
Hour |
Hour |
||||||||
1 |
24 |
48 |
72 |
1 |
24 |
48 |
72 |
||
1 |
Left |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Left |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
Right |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Note: Refer section 2.12 for Irritation Scores
Acute Dermal Irritation Study of DABQUEL COMPLEX CuP in Rabbits
Table 2: Clinical Observations and Body Weight (kg) of Individual Rabbit
Sex: Male
Rabbit N° |
Clinical Observations made on Day |
Body Weights (kg) |
||||
0 |
1 |
2 |
3 |
Before Treatment |
At Termination |
|
1 |
1 |
1 |
1 |
1 |
2.426 |
2.515 |
2 |
1 |
1 |
1 |
1 |
2.406 |
2.531 |
3 |
1 |
1 |
1 |
1 |
2.560 |
2.651 |
Key: 0 = Day of dermal application
Clinical Sign: 1 = Normal
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 15, 2016 - March 10, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: well documented GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- yes
- Remarks:
- Exception to OECD guideline 405, for not testing weight of evidence analysis by the test facility.
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Sainath Agencies, Hyderabad, India
- Age at study initiation: 4 to 5 months
- Weight at study initiation: Minimum: 2.358, Maximum: 2.392
- Housing: individually in stainless steel wire meshed cages
- Diet (e.g. ad libitum): Teklad certified Global High Fiber Rabbit pellet Feed manufactured by Harlan, USA ad libitum
- Water (e.g. ad libitum): UV sterilised drinking water filtered through Kent Reverse Osmosis water filtration system ad libitum
- Acclimation period: 8 - 10 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 22 °C
- Humidity (%): 64 to 65%
- Air changes (per hr): Minimum 15 air changes/hour
- Photoperiod (hrs dark / hrs light): 12 h artificial light and 12 h darkness, light hours being 06:00 - 18:00 h except light was kept ON at the time of the subcutaneous injection during night hours. Photoperiod was maintained through automatic timer.
Animal Identification
Each rabbit was serially numbered on the ear using a tattoo machine on day 1 of acclimatisation. Appropriate labels were attached to the cages indicating the study number, test item code, sex, dose, type of study, cage number and animal number. - Vehicle:
- other: distilled water
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 mL
- Concentration (if solution): 1 % solution in distilled water
VEHICLE
- Amount(s) applied (volume or weight with unit): distilled water, test item solved in it
- Concentration (if solution): 1 % - Duration of treatment / exposure:
- 8 hours
- Observation period (in vivo):
- 72 hours
- Number of animals or in vitro replicates:
- 3
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): with 0.9 % normal saline
- Time after start of exposure: 24 after treatment
SCORING SYSTEM: according to OECD 405
TOOL USED TO ASSESS SCORE: fluorescein - Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- other: 24, 48 and 72 hours
- Score:
- 0
- Reversibility:
- other: not applicable
- Irritant / corrosive response data:
- Conjunctival redness was evident at 1, 24 and 48 h in rabbit N° 1, which was resolved by 72 h and at 1 and 24 h in rabbit N° 2 and 3, which was resolved by 48 h post TIA. Conjunctival chemosis was evident at 1 and 24 h in rabbit N° 1, which was resolved by 48 h post TIA and at 1 h post TIA in rabbit N° 2 and 3, which was resolved by 24 h post TIA. The animal mean eye irritation scores of the 24, 48 and 72 h post-TIA observation were 0.00, 0.00, 0.00 for corneal opacity, 0.00, 0.00, 0.00 for iris effects, 0.67, 0.33, 0.33 for conjunctival redness and 0.33, 0.00, 0.00 for conjunctival chemosis for rabbit N° 1, 2 and 3, respectively (TABLE 1). Examination with fluorescein dye and cobalt blue filter at 24 h post TIA revealed no corneal epithelium damage in all rabbits.
- Interpretation of results:
- not irritating
- Conclusions:
- Examination with fluorescein dye and cobalt blue filter at 24 h post TIA revealed no corneal epithelium damage in all rabbits. Based on the results of this study, an indication of the classification for DABQUEL COMPLEX CuP is as follows:
Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2015): Not classified as an eye irritant. - Executive summary:
In an acute eye irritation study, 3 adult male New Zealand White rabbits were given a single ocular application of 0.1 mL DABQUEL COMPLEX CuP in the right eye of the rabbit while the contralateral eye remained untreated and served as the control. Initially one rabbit was tested. Based on the results obtained at 24 h post Test Item Application (TIA), the irritation response was confirmed by testing two additional rabbits simultaneously. Observations were made at 1, 24, 48 and 72 h post TIA. General health status was also checked.
Conjunctival effects were evident at 1 h, 24 h and 48 h which resolved by 72 h post TIA. The animal mean eye irritation scores of the 24, 48 and 72 h post TIA observation were 0.00, 0.00, 0.00 for corneal opacity, 0.00, 0.00, 0.00 for iris effects, 0.67, 0.33, 0.33 for conjunctival redness and 0.33, 0.00, 0.00 for conjunctival chemosis for rabbit N° 1, 2 and 3, respectively.
Examination with fluorescein dye and cobalt blue filter at 24 h post TIA revealed no corneal epithelium damage in all rabbits.
The control eye did not show any abnormal reaction during the study. Moreover, there were no signs of systemic toxicity in any animal observed.
Based on the results of this study, an indication of the classification for DABQUEL COMPLEX CuP is as follows:
Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2015): Not classified as an eye irritant.
Reference
Mean Eye Irritation Scores
The animal mean eye irritation scores observed for corneal opacity (0.00), iritis (0.00), conjunctival redness (0.33 to 0.67) and conjunctival chemosis (0.00 to 0.33) following grading at 24, 48 and 72 h post TIA.
Narrative Description of Eye Irritation
Treated Eye
At 1 h post-TIA, the treated eye of all three rabbits revealed conjunctival redness [some blood vessels definitely hyperaemic (injected); score of 1] and conjunctival chemosis [some swelling above normal (includes nictitating membranes); score of 1].
At 24 h post-TIA, the treated eye revealed conjunctival redness [some blood vessels definitely hyperaemic (injected) in all three rabbits; score of 1] and conjunctival chemosis [some swelling above normal (includes nictitating membranes) in rabbit N° 1, score of 1].
At 48 h post-TIA, the treated eye revealed conjunctival redness (some blood vessels definitely hyperaemic (injected) in rabbit N°1; score of 1) while rabbit N°2 and 3 recovered completely and appeared normal throughout the experimental period.
At 72 h post-TIA, the treated eye of rabbit N° 1 recovered completely and appeared normal.
Corneal opacity and iritis were not observed in any of the rabbits throughout the experimental period.
Examination with fluorescein dye and cobalt blue filter [corneal epithelium damage showing as green fluorescein staining] revealed no (area) corneal epithelium damage in all three rabbits at 24 h post TIA.
Control Eye
No abnormalities were detected in the control eye of each rabbit during the course of this study (Table 3). No disruption of corneal epithelium was observed during the examination with fluorescein dye and cobalt blue filter.
Clinical Observations other than Eye Irritation
Other than eye irritation, no signs of systemic toxicity including clinical observation and body weight were observed in the rabbits throughout the experimental period.
Interpretation of Results
Conjunctival redness was evident at 1, 24 and 48 h in rabbit N° 1 which was resolved by 72 h post-TIA and at 1 and 24 h in rabbit N° 2 and 3 which resolved by 48 h post TIA. Conjunctival chemosis was evident at 1 and 24 h in rabbit N° 1 which resolved by 24 h post-TIA. The animal mean eye irritation scores of the 24, 48 and 72 h post-TIA observation were 0.00, 0.00, 0.00 for corneal opacity, 0.00, 0.00, 0.00 for iris effects, 0.67, 0.33, 0.33 for conjunctival redness and 0.33, 0.00, 0.00 for conjunctival chemosis for rabbit N° 1, 2 and 3, respectively (TABLE 1). Examination with fluorescein dye and cobalt blue filter at 24 h post TIA revealed no corneal epithelium damage in all rabbits.
Conclusion
Based on the results of this study, an indication of the classification for DABQUEL COMPLEX CuP is as follows:
Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2015): Not classified as an eye irritant
Acute Eye Irritation Study of DABQUEL COMPLEX CuP in Rabbits
TABLE1: Mean Eye Irritation Scores
Sex: Female
Rabbit N° |
Mean Score at 24, 48 and 72 Hours |
|||
Opacity: Degree of Density |
Iris Lesion |
Conjunctivae |
||
Redness |
Chemosis |
|||
1 |
0.00 |
0.00 |
0.67 |
0.33 |
2 |
0.00 |
0.00 |
0.33 |
0.00 |
3 |
0.00 |
0.00 |
0.33 |
0.00 |
Acute Eye Irritation Study of DABQUEL COMPLEX CuP in Rabbits
Table 2: Clinical Observations (Non Ocular) and Body Weight (kg) of Individual Rabbit
A. Clinical Observation (Non Ocular)
Sex: Female
Rabbit N° |
Observations made on Day |
|||
0 |
1 |
2 |
3 |
|
1 |
1 |
1 |
1 |
1 |
2 |
1 |
1 |
1 |
1 |
3 |
1 |
1 |
1 |
1 |
Key: 0 = Day of treatment
1 = Normal
B. Body Weight Record
Rabbit N° |
Body Weight (kg) |
|
Initial (Day 0) |
Termination (72 h) |
|
1 |
2.358 |
2.460 |
2 |
2.392 |
2.493 |
3 |
2.387 |
2.513 |
Acute Eye Irritation Study of DABQUEL COMPLEX CuP in Rabbits
Table 3 :Individual Scores of Eye Reactions Post Application
Control Eye
Sex: Female
Rabbit N° |
1 |
2 |
3 |
|||||||||
Site of Application |
Left |
Left |
Left |
|||||||||
Reaction |
Hour |
Hour |
Hour |
|||||||||
1 |
24 |
48 |
72 |
1 |
24 |
48 |
72 |
1 |
24 |
48 |
72 |
|
Opacity: Degree of Density |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Iris |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Conjunctivae (Redness) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Conjunctivae (Chemosis) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Treated Eye
Rabbit N° |
1 |
2 |
3 |
|||||||||
Site of Application |
Right |
Right |
Right |
|||||||||
Reaction |
Hour |
Hour |
Hour |
|||||||||
1 |
24 |
48 |
72 |
1 |
24 |
48 |
72 |
1 |
24 |
48 |
72 |
|
Opacity: Degree of Density |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Iris |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Conjunctivae (Redness) |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
1 |
1 |
0 |
0 |
Conjunctivae (Chemosis) |
1 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Acute Eye Irritation Study of DABQUEL COMPLEX CuP in Rabbits
Table 4: Individual Corneal Observations 24 h Post Application using Fluorescein Dye Staining
Control Eye
Sex: Female
Rabbit N° |
Control Eye |
Fluorescein Staining Response |
Details of Corneal Damage Observed in Control Eye |
1 |
Left |
Negative |
No corneal epithelium damage was observed. |
2 |
Left |
Negative |
No corneal epithelium damage was observed. |
3 |
Left |
Negative |
No corneal epithelium damage was observed. |
Treated Eye
Rabbit N° |
Treated Eye |
Fluorescein Staining Response |
Details of Corneal Damage Observed in Treated Eye |
1 |
Right |
Negative |
No corneal epithelium damage was observed. |
2 |
Right |
Negative |
No corneal epithelium damage was observed. |
3 |
Right |
Negative |
No corneal epithelium damage was observed. |
Acute Eye Irritation Study of DABQUEL COMPLEX CuP in Rabbits
Table 5: Details of Injections and Applications
Rabbit N° |
On Days |
Administration of Systemic Analgesics (Subcutaneous Injection) |
Administration of Topical Anaesthetic (1 to 2 drops) 0.5% Proparacaine Hydrochloride |
Time of Test Item Application (0.1 mL) |
|
Buprenorphine Hydrochloride (0.01 mg/kg body weight) |
Meloxicam (0.5 mg/kg body weight) |
||||
1 |
0 |
11:45 am & 8:49 pm |
8:49 pm |
12:40 pm |
12:45 pm |
1 |
8:36 am and 8:53 pm |
8:53 pm |
- |
- |
|
2 |
8:36 am and 8:51 pm |
8:51 pm |
- |
- |
|
3 |
8:51 am |
- |
- |
- |
|
2 and 3 |
0 |
11:42 am to 11:43 am & 8:52 pm to 8:53 pm |
8:52 pm to 8:53 pm |
12:37 pm to 12:38 pm |
12:42 pm to 12:43 pm |
1 |
8:53 am to 8:54 am and 8:40 pm to 8:41 pm |
8:40 pm to 8:41 pm |
- |
- |
|
2 |
8:51 am to 8:52 pm |
- |
- |
- |
Key : - = Not applicable
Note: Day 0 = Day of treatment
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Skin Irritation
Key study
The skin irritation potential of Copper glucoheptonate (CAS 1821694-24-9) was tested in rabbits (Patel, 2016A, acc. OECD 404). For this acute dermal irritation study, three adult male New Zealand White rabbits were dermally exposed to 500 mg copper glucoheptonate (pulverised and moistened with 0.5 mL distilled water, Copper content 12.5 %), for 4 h (day 0), applied to approximately 6 cm² area of skin. Initially one rabbit was tested with a single patch applied evenly to the intact skin for a period of 4 h. Based on the observations at 24 h post patch removal, two additional rabbits were tested simultaneously to confirm the irritation response. The control skin site of each rabbit was untreated. The treated and the control sites were covered with a gauze patch that was secured at the margins by non-irritating tape for a period of 4 h. At the end of the 4 h exposure period, the residual test item was removed with cotton soaked in distilled water. The skin reactions of each rabbit were observed at 1, 24, 48 and 72 h post patch removal. Irritation was scored according to OECD 404. As a result, there were no signs of systemic adverse effect in any treated rabbits. Erythema was evident at 1 h in all rabbits which resolved by 24 h post patch removal in all rabbits. The mean dermal irritation scores at 24, 48 and 72 h post-patch removal for individual animals were 0.00, 0.00, 0.00 for erythema and 0.00, 0.00, 0.00 for oedema, respectively.
Read-across approach
Copper glucoheptonate is a chelate compound consisting of two molecules of sugar like glucoheptonic acid and two copper ions. Data on structurally similar gluconic acid, its derivatives and organic and inorganic copper compounds have been taken into account to assess the irritating potential of copper glucoheptonate.
Gluconic acid and its derivatives
Primary dermal irritation tests with 0.5 mL of a 50% solution of gluconic acid (pH 1.8) in 12 albino rabbits demonstrated, that – as all the effects have cleared up after a 72 hours observation period – the test substance is not a dermal irritant (TNO, 1984, cited in SIDS, 2004).
The 2014 Cosmetic Ingredient Review Expert Panel acknowledged that the group of monosaccharides, disaccharides, and their related Ingredients, including calcium gluconate and gluconic acid, are safe for humans at concentrations as used in cosmetics. Based on the clinical experience of the Panel, there is little concern that these ingredients are irritants or sensitizers (CIR, 2014).
Organic and inorganic copper compounds
There are several unpublished animal study results provided for the preparation of a voluntary Risk Assessment Report (EU VRAR, 2007). Since Copper glucoheptonate is a water soluble copper compound, the results of the irritation studies with soluble and slightly soluble inorganic copper compounds i.e. copper sulphate pentahydrate and copper oxychloride have been taken into account. In guideline studies on dermal irritation, no signs of skin irritation or weak irritation of the skin were observed in animals treated with these compounds. The dermal irritation scores were under the cut-off values triggering C&L as skin irritant. The available data for copper sulphate pentahydrate and copper oxychloride do not meet the EU classification criteria requiring classification as irritant. There are no data available indicating that copper compounds are skin irritants in humans (EU VRAR, 2007). Similarly, a copper containing organic substance Tripeptide-Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+ (CAS 89030-95-5) was also evaluated as safe for the use in cosmetics as a skin condition agent (CIR, 2014b). Moreover, copper showed wound healing effect in in vivo and in in vitro studies (Simeon et al., 1999; McCormack et al., 2001; please refer to robust study summary in the section "Skin sensitisation").
EFSA (Scientific Opinion, 2015) has evaluated the safety and efficacy of copper compounds (E4) (cupric acetate, monohydrate; basic cupric carbonate, monohydrate; cupric chloride, dihydrate; cupric oxide; cupric sulphate, pentahydrate; cupric chelate of amino acids, hydrate; cupric chelate of glycine, hydrate) as feed additives for all animal species. Copper salts can act as skin and eye irritants: skin eczema, conjunctivitis and even ulceration and turbidity of the cornea may occur in exposed workers (ACGIH, 1991, cited in EFSA, 2015). In the absence of specific studies and considering the toxicological profiles of copper compounds, the FEEDAP Panel retains that the compounds under evaluation should be considered as irritants to the skin and eye (EFSA, 2015).
There are conflicting results from animal studies and case reports mentioned in SCOEL (2013) and WHO (2002) reports on copper and its inorganic compounds. The skin irritation potential seems to depend on the anion (sulphate, chloride, carbonate etc.). The following statements have been found in the reports: "Dermal contact with copper salts may cause irritation to the skin, itching and erythema" in animals and humans (no further details) (WHO 2002); "Dermal application of metallic copper caused follicular reactions in guinea pigs (Greim, 2004, cited in SCOEL., 2013)". Copper monochloride (CAS 7758 -89 -6) was irritating in an acute dermal toxicity study in rats (SIDS, 2005). Necroses were observed after dermal exposure of mice to copper chloride in DMSO at concentrations ≥2.5 % (Basketter et al., 1999). On the other hand, "Copper sulphate probably is mildly or non-irritant to intact skin" is reported in WHO report (2002).
Eye irritation
Key study
The eye irritation potential of copper glucoheptonate (CAS 1821694-24-9) was tested in vivo in rabbits (Patel, 2016B, acc. OECD 405). For this acute eye irritation study, 3 adult male New Zealand White rabbits were given a single ocular application of 0.1 mL copper glucoheptonate (pulverised and moistened with distilled water, Copper content 12.5 %) in the right eye, while the contralateral eye remained untreated and served as the control. Initially one rabbit was tested. Based on the results obtained at 24 h post Test Item Application (TIA), the irritation response was confirmed by testing two additional rabbits simultaneously. Observations were made at 1, 24, 48 and 72 h post TIA. General health status was also checked.
As a result, conjunctival effects were evident at 1 h, 24 h and 48 h which resolved by 72 h post TIA. The animal mean eye irritation scores of the 24, 48 and 72 h post TIA observation were 0.00, 0.00, 0.00 for corneal opacity, 0.00, 0.00, 0.00 for iris effects, 0.67, 0.33, 0.33 for conjunctival redness and 0.33, 0.00, 0.00 for conjunctival chemosis for rabbit N° 1, 2 and 3, respectively. Examination with fluorescein dye and cobalt blue filter at 24 h post TIA revealed no corneal epithelium damage in all rabbits. The control eye did not show any abnormal reaction during the study. Moreover, there were no signs of systemic toxicity in any animal observed. Based on the results of this study, an indication of the classification for copper glucoheptonate is as follows: Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2015): Not classified as an eye irritant.
Read-across
Gluconic acid and its derivatives
The eye irritation potential of the structurally similar analogues gluconic acid and its derivatives was evaluated by the 2014 Cosmetic Ingredient Review Expert Panel (CIR, 2014). The results of the following studies originate also from the OECD SIDS report (2004) on gluconate category.
In an in vitro study, the ocular irritation potential of a 50% aq. solution of gluconic acid was evaluated in vitro in enucleated rabbit eyes (TNO, 1984; cited in OECD SIDS, 2004). The test material was applied to four eyes and observed over a period of 4 h following application. Slight corneal swelling and slight permeability of the superficial epithelial cells were not considered to be of any toxicological significance.
In an in vivo study, a 50% aq. solution of gluconic acid was not irritating to rabbit eyes. A 50% solution of gluconic acid (pH 1.8; 0.1 ml) was instilled into the conjunctival sac of one eye in nine New Zealand white rabbits; the contralateral eye served as an untreated control. The eyes of three animals were rinsed after 2 sec, and of another three animals after 4 sec; the eyes of the remaining three animals were not rinsed. The eyes were examined for irritation 1, 24, 48, and 72 h and 7 days after instillation. Slight redness and conjunctival swelling were observed initially; however, no signs of irritation were observed after 72 h.
The Expert Panel concluded that monosaccharides, disaccharides, and their related Ingredients, including calcium gluconate and gluconic acid, are safe for humans at concentrations as used in cosmetics (CIR, 2014). The substances in this category are not irritating to eyes. The same conclusion is done in the OECD SIDS report for gluconates and the derivatives: "These compounds are neither irritant to the eye or the skin nor show sensitizing properties" (OECD SIDS, 2004).
Organic and inorganic copper compounds
Similarly to skin irritation potential of inorganic copper compounds, the grade of eye irritation depends on anion and the oxidation state of copper. A number of unpublished animal studies have been made available which have investigated eye irritant properties of several copper compounds and copper powder (EU VRAR, 2007). It is reported, that Copper (I) oxide caused eye irritation in rabbits in a number of tests, mostly of mild to moderate severity and is proposed to be classified as eye irritant. Copper sulphate pentahydrate caused fairly severe and persistent eye irritation in rabbits. In contrast, Copper (II) oxide, copper oxychloride and copper powder all caused mild and reversible eye irritation in rabbits; the data do not meet the criteria requiring these substances to be classified as irritant.
Other literature sources report that contact of copper salts with the eye may lead to conjunctivitis, ulceration, turbidity of the cornea and adhesion of the eyelids to the eye (SCOEL, 2013; WHO, 2002). Eye irritation has been reported by workers exposed to copper dust (ATSDR, 2004; Askergren and Mellgren, 1975).
EFSA (Scientific Opinion, 2015) has evaluated the safety and efficacy of copper compounds (E4) (cupric acetate, monohydrate; basic cupric carbonate, monohydrate; cupric chloride, dihydrate; cupric oxide; cupric sulphate, pentahydrate; cupric chelate of amino acids, hydrate; cupric chelate of glycine, hydrate) as feed additives for all animal species. Copper salts can act as skin and eye irritants: skin eczema, conjunctivitis and even ulceration and turbidity of the cornea may occur in exposed workers (ACGIH, 1991, cited in EFSA, 2015). In the absence of specific studies and considering the toxicological profiles of copper compounds, the FEEDAP Panel retains that the compounds under evaluation should be considered as irritants to the skin and eye (EFSA, 2015).
Respiratory irritation
Cases of irritation of the respiratory tract after inhalation of copper containing compounds are reported in occupationally exposed workers, in unintentionally exposed persons and in animal inhalation studies (SCOEL, 2013; ATSDR, 2004; WHO, 2002).
In Scientific Opinion of EFSA (2015) on the safety and efficacy of copper compounds (E4) (cupric acetate, monohydrate; basic cupric carbonate, monohydrate; cupric chloride, dihydrate; cupric oxide; cupric sulphate, pentahydrate; cupric chelate of amino acids, hydrate; cupric chelate of glycine, hydrate) as feed additives for all animal species, it was concluded that these substances should be considered as hazardous by inhalation. Since the dusting potential of these additives - except the cupric chloride, dihydrate - is high (209 to 11800 mg/m³), the estimates of copper exposure resulting from the amount of copper in dust would lead to an exceedance of the OEL for copper (0.01 mg/m³ respirable fraction) by several orders of magnitude (EFSA, 2015).
Justification for classification or non-classification
Based on the results of the available in vivo key study (Patel, 2016a,b), Copper glucoheptonate (CAS 1821694 -24 -9) does not meet criteria for classification and labelling as a skin or eye irritant according to European Regulation (EC) No. 1272/2008.
Based on the available medical and scientific literature data, most of the organic and inorganic copper compounds were irritaing to skin and eyes and caused respiratory irritation. Structurally similar gluconates and their derivatives are assessed to be not irritating to skin and eyes. Since copper glucoheptonate is a water soluble compound, attention was given to the test results of soluble copper compounds. Insoluble copper compounds do not possess irritating properties or are weakly irritating. In contrast, well soluble copper compounds are irritating to skin and severe irritating to eyes. However, although Copper glucoheptonate is a soluble compound it was not irritating to eyes of rabbits in the in vivo study.
Since Copper glucoheptonate has a respirable particle fraction (9.86 %) under 100 µm (please refer to granulometry study; Dabeer, 2014), theoretically, a respiratory irritating hazard by inhalation cannot be ruled out. However, in the absence of dusting potential of copper glucoheptonate, and in the absence of cases of respiratory irritation to this product in humans, no conclusion can be made on the relevance of this fraction for respiratory irritation. Therefore, Copper glucoheptonate does not need to be classified and labelled as respiratory irritant taking into account the provisions laid down in Council Directive 67/548/EEC and CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.